title: Editorial: The AIDS crisis, cost-effectiveness and academic activism.
authors.forename: Marleen
authors.initials: M
authors.lastname: Boelaert
authors.forename: Wim
authors.initials: W
authors.lastname: Van Damme
authors.forename: Bruno
authors.initials: B
authors.lastname: Meessen
authors.forename: Patrick
authors.initials: P
authors.lastname: Van der Stuyft
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy* / Q000517:prevention & control; D017954:Africa South of the Sahara; D023241:Antiretroviral Therapy, Highly Active / Q000191:economics; D003362:Cost-Benefit Analysis; D017850:Economics, Pharmaceutical; D017048:Health Care Costs; D006801:Humans; D007391:International Cooperation